Saxagliptin Tablet, Film Coated
Product Images NDC 65862-825

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Saxagliptin (NDC 65862-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Mean Change From Baseline In A1c In A Placebo-controlled Trial Of Saxagliptin As Add-on Combination Therapy With Metformin (Saxagliptin Figure1)

A line graph depicting the mean percent change from baseline in A1C over 24 weeks for three groups: Saxagliptin 2.5 mg plus Metformin, Saxagliptin 5 mg plus Metformin, and Placebo plus Metformin. The chart shows A1C levels decreasing over time for the Saxagliptin groups compared to the Placebo group, with error bars shown for the 24-week last observation carried forward (LOCF) data.*

FDA Label Image

Figure 2 (Saxagliptin Figure2)

Kaplan-Meier cumulative event probability graph comparing Saxagliptin (S) and Placebo (P) over days from randomization, showing nearly identical event rates with hazard ratio 1.00 (95.1% CI: 0.89, 1.12). Participant counts at risk are listed below the x-axis for each treatment group over time.*

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablet Bottle))

Label for Saxagliptin Tablets 2.5 mg film-coated oral tablets by Aurobindo Pharma Limited. The label includes NDC 65862-825-30, dosage information indicating each tablet contains 2.5 mg saxagliptin, storage instructions, and directions to provide the Medication Guide. It also states the product is made in India and distributed by Aurobindo Pharma USA, Inc. The package contains 30 tablets.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablet Bottle))

Label for Saxagliptin Tablets 5 mg film-coated oral tablets by Aurobindo Pharma Limited. The label states each tablet contains 5.58 mg saxagliptin hydrochloride equivalent to 5 mg saxagliptin. The package contains 30 tablets. The label includes storage instructions and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Saxagliptin Monohydrate Chemical Structure (Saxagliptin Str)

Chemical structure of Saxagliptin, depicted as a detailed molecular diagram showing the arrangement of atoms and bonds, including functional groups such as a hydroxyl (OH), amino (NH2), cyano (CN), and a water molecule (H2O) associated with the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.